Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0.0196 | 0.5 |
Schistosoma mansoni | DNA helicase recq5 | 0.0019 | 0.0218 | 0.0218 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0089 | 0.0081 |
Echinococcus multilocularis | lamin | 0.0028 | 0.041 | 0.0324 |
Echinococcus granulosus | lamin dm0 | 0.0028 | 0.041 | 0.0324 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0435 | 0.0427 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.0008 | 0.0008 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0462 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0018 | 0.0196 | 0.0196 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0019 | 0.0218 | 0.0046 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0218 | 0.5017 |
Echinococcus granulosus | intermediate filament protein | 0.0028 | 0.041 | 0.0324 |
Brugia malayi | Fibroblast growth factor family protein | 0.0327 | 0.7018 | 0.6981 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0008 | 0.0191 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0078 | 0.007 |
Loa Loa (eye worm) | intermediate filament protein | 0.0028 | 0.041 | 0.0402 |
Echinococcus granulosus | ATP dependent DNA helicase Q1 | 0.0019 | 0.0218 | 0.013 |
Loa Loa (eye worm) | hypothetical protein | 0.0118 | 0.2401 | 0.2394 |
Giardia lamblia | Hypothetical protein | 0.0327 | 0.7018 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.0019 | 0.0218 | 0.0218 |
Plasmodium vivax | SET domain protein, putative | 0.0029 | 0.0435 | 1 |
Echinococcus multilocularis | musashi | 0.0028 | 0.041 | 0.0324 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0462 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0327 | 0.7018 | 0.7016 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0019 | 0.0218 | 0.021 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0462 | 1 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q5 | 0.0019 | 0.0218 | 0.013 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0.0196 | 0.8958 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0.0196 | 0.4514 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.041 | 0.0402 |
Echinococcus multilocularis | bloom syndrome protein | 0.0019 | 0.0218 | 0.013 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0218 | 0.0097 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0018 | 0.0196 | 0.8958 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0029 | 0.0435 | 0.0435 |
Leishmania major | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0218 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0327 | 0.7018 | 0.7016 |
Brugia malayi | Pre-SET motif family protein | 0.0029 | 0.0435 | 0.0317 |
Loa Loa (eye worm) | RecQ helicase | 0.0019 | 0.0218 | 0.021 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0028 | 0.0412 | 0.0325 |
Onchocerca volvulus | 0.0232 | 0.4911 | 1 | |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0435 | 0.0435 |
Schistosoma mansoni | ap endonuclease | 0.0018 | 0.0196 | 0.0196 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0008 | 0.0191 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0029 | 0.0435 | 0.0349 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0008 | 0.0381 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0018 | 0.0196 | 0.0108 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0028 | 0.041 | 0.0292 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0018 | 0.0196 | 0.0188 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0019 | 0.0218 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase Q1 | 0.0019 | 0.0218 | 0.013 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0028 | 0.041 | 0.0402 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0462 | 1 | 1 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0218 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0122 | 0.0114 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0218 | 0.021 |
Schistosoma mansoni | intermediate filament proteins | 0.0028 | 0.041 | 0.041 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0.0196 | 1 |
Schistosoma mansoni | lamin | 0.0028 | 0.041 | 0.041 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0029 | 0.0435 | 0.0349 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0029 | 0.0435 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0029 | 0.0435 | 0.0349 |
Echinococcus granulosus | ATP dependent DNA helicase Q5 | 0.0019 | 0.0218 | 0.013 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0019 | 0.0218 | 0.0032 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0435 | 0.0435 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0019 | 0.0218 | 0.0046 |
Trichomonas vaginalis | set domain proteins, putative | 0.0232 | 0.4911 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0029 | 0.0435 | 0.0435 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0218 | 0.5017 |
Brugia malayi | Pre-SET motif family protein | 0.0204 | 0.4289 | 0.4218 |
Entamoeba histolytica | recQ family helicase, putative | 0.0019 | 0.0218 | 1 |
Echinococcus granulosus | bloom syndrome protein | 0.0019 | 0.0218 | 0.013 |
Brugia malayi | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0218 | 0.0097 |
Brugia malayi | intermediate filament protein | 0.0028 | 0.041 | 0.0292 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0019 | 0.0218 | 0.0046 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0018 | 0.0196 | 0.8998 |
Brugia malayi | Fibroblast growth factor family protein | 0.0327 | 0.7018 | 0.6981 |
Toxoplasma gondii | exonuclease III APE | 0.0018 | 0.0196 | 0.4514 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0204 | 0.4289 | 0.4284 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0008 | 0.00000000017681 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0078 | 0.007 |
Echinococcus granulosus | lamin | 0.0028 | 0.041 | 0.0324 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.0019 | 0.0218 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0018 | 0.0196 | 0.0108 |
Echinococcus multilocularis | lamin dm0 | 0.0028 | 0.041 | 0.0324 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0218 | 1 |
Onchocerca volvulus | 0.0029 | 0.0435 | 0.0055 | |
Brugia malayi | Protein kinase domain containing protein | 0.0119 | 0.2421 | 0.2327 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0.0196 | 0.5 |
Schistosoma mansoni | lamin | 0.0028 | 0.041 | 0.041 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0019 | 0.0218 | 0.0097 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0.0196 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0399 | 0.0391 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0018 | 0.0196 | 0.0075 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.4 ug ml-1 | Antibacterial activity was determined against gram negative organism, E. cloacae MA2646 | ChEMBL. | 1848296 |
MIC (functional) | = 0.4 ug ml-1 | Antibacterial activity was determined against gram negative organism, E. coli vogel | ChEMBL. | 1848296 |
MIC (functional) | = 0.4 ug ml-1 | Antibacterial activity was determined against gram negative organism, E. coli vogel | ChEMBL. | 1848296 |
MIC (functional) | = 0.8 ug ml-1 | Antibacterial activity was determined against gram negative organism, K. pneumonia MGH-2 | ChEMBL. | 1848296 |
MIC (functional) | = 1.6 ug ml-1 | Antibacterial activity was determined against gram negative organism, P. rettgeri. M1771 | ChEMBL. | 1848296 |
MIC (functional) | = 1.6 ug ml-1 | Antibacterial activity was determined against gram negative organism, P. aeruginosa UI-18 | ChEMBL. | 1848296 |
MIC (functional) | = 1.6 ug ml-1 | Antibacterial activity was determined against gram positive organism, S. aureus UC76 | ChEMBL. | 1848296 |
MIC (functional) | = 5 ug ml-1 | Minimum inhibitory concentration against E. coli DNA-gyrase in supercoiling assay | ChEMBL. | 1848296 |
MIC (functional) | = 5 ug ml-1 | Minimum inhibitory concentration against E. coli DNA-gyrase in supercoiling assay | ChEMBL. | 1848296 |
MIC (functional) | = 12.5 ug ml-1 | Antibacterial activity was determined against gram positive organism, S. auerus H228 | ChEMBL. | 1848296 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity was determined against gram positive organism, S. faecalis MGH-2 | ChEMBL. | 1848296 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity was determined against gram positive organism, S. pneumonia SV-1 | ChEMBL. | 1848296 |
MIC (functional) | = 25 ug ml-1 | Antibacterial activity was determined against gram positive organism, S. pyogenes C203 | ChEMBL. | 1848296 |
Ratio (functional) | = 0.8 | MIC ratio measured as the mean MICs of gram-negative bacteria | ChEMBL. | 1848296 |
Ratio (functional) | = 12.56 | MIC ratio measured as the mean MICs of gram-positive bacteria | ChEMBL. | 1848296 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.